Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GCTKNASDAQ:NRXSNASDAQ:NXGLNASDAQ:PETV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGCTKGlucoTrack$6.32+1.4%$8.71$5.16▼$3,756.00$2.98M-0.1944,892 shs150,611 shsNRXSNeurAxis$2.54$2.42$1.33▼$6.20$18.33M3.34417,934 shs126,026 shsNXGLNexGel$2.36-2.1%$2.47$1.84▼$5.10$18.45M0.5270,374 shs13,957 shsPETVPetVivo$0.80+14.2%$0.68$0.29▼$0.98$19.41M0.8720,614 shs51,445 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGCTKGlucoTrack+1.44%+10.99%-24.76%-64.71%-99.77%NRXSNeurAxis0.00%+10.92%-20.63%+9.96%-9.29%NXGLNexGel-2.07%-7.81%+6.31%-12.59%+7.27%PETVPetVivo+14.21%+12.92%+8.66%+53.75%+45.36%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGCTKGlucoTrack0.3667 of 5 stars0.05.00.00.00.00.80.0NRXSNeurAxis2.9119 of 5 stars3.53.00.00.02.83.30.0NXGLNexGel1.1052 of 5 stars0.05.00.00.01.62.50.0PETVPetVivoN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGCTKGlucoTrack 0.00N/AN/AN/ANRXSNeurAxis 3.00Buy$7.00175.59% UpsideNXGLNexGel 0.00N/AN/AN/APETVPetVivo 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest GCTK, NRXS, NXGL, and PETV Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/16/2025NRXSNeurAxisCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy6/16/2025NRXSNeurAxisCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy$7.00(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGCTKGlucoTrackN/AN/AN/AN/A($983.35) per shareN/ANRXSNeurAxis$2.93M6.24N/AN/A($0.27) per share-9.41NXGLNexGel$8.69M2.08N/AN/A$0.90 per share2.62PETVPetVivo$1.05M18.55N/AN/A($0.03) per share-26.65Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGCTKGlucoTrack-$22.60M-$56.60N/A∞N/AN/AN/A-544.87%N/ANRXSNeurAxis-$14.63M-$1.19N/A∞N/A-492.76%N/A-641.25%N/ANXGLNexGel-$3.28M-$0.45N/A∞N/A-30.80%-54.95%-27.84%N/APETVPetVivo-$10.95M-$0.45N/A∞N/A-902.82%-4,813.07%-281.78%6/26/2025 (Estimated)Latest GCTK, NRXS, NXGL, and PETV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025GCTKGlucoTrackN/A-$20.40N/A-$0.67N/AN/A5/13/2025Q1 2025NXGLNexGel-$0.10-$0.09+$0.01-$0.09$2.73 million$2.81 million3/24/2025Q4 2024NXGLNexGel-$0.10-$0.08+$0.02-$0.11$2.99 million$3.04 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGCTKGlucoTrackN/AN/AN/AN/AN/ANRXSNeurAxisN/AN/AN/AN/AN/ANXGLNexGelN/AN/AN/AN/AN/APETVPetVivoN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGCTKGlucoTrack0.034.854.85NRXSNeurAxisN/A0.240.23NXGLNexGel0.151.881.15PETVPetVivo0.020.420.47Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGCTKGlucoTrack10.92%NRXSNeurAxis11.77%NXGLNexGel2.21%PETVPetVivo24.55%Insider OwnershipCompanyInsider OwnershipGCTKGlucoTrack12.91%NRXSNeurAxis26.40%NXGLNexGel20.55%PETVPetVivo10.84%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGCTKGlucoTrack5480,000416,000Not OptionableNRXSNeurAxis197.22 million6.09 millionNot OptionableNXGLNexGel107.65 million6.08 millionNot OptionablePETVPetVivo2024.27 million19.06 millionNot OptionableGCTK, NRXS, NXGL, and PETV HeadlinesRecent News About These CompaniesPetVivo (NASDAQ:PETV) Shares Up 14.2% - Still a Buy?June 21 at 2:15 AM | americanbankingnews.comPETVIVO HOLDINGS, INC. ANNOUNCES INVESTOR EXERCISE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERINGJune 20 at 8:00 AM | globenewswire.comPetVivo Holdings Secures $3 Million from Equity OfferingJune 20 at 6:48 AM | tipranks.comPetVivo Holdings Secures $200K in Equity FinancingJune 16, 2025 | tipranks.comNew to The Street Announces Upcoming Bloomberg Air Dates Featuring FLOKI, BioVie Pharmaceuticals, Beeline, Arrive AI, and CommercialvilleJune 7, 2025 | indystar.comPetVivo and Commonwealth Partner to Advance Equine Wellness Across Thoroughbred RacingJune 6, 2025 | globenewswire.comDigital Landia, LLC, in Cooperation with PetVivo Holdings, Inc., Announces Invite-Only MVP Availability Amid Stress-Testing & Debugging PhaseMay 29, 2025 | globenewswire.comPetVivo Holdings Inc (PETV)May 27, 2025 | investing.comPetvivo Holdings, Inc. and PiezoBioMembrane Inc. Announce Master Services Agreement to Jointly Develop Innovative Functional BiomaterialsMay 22, 2025 | globenewswire.comDIGITAL LANDIA, LLC IN COOPERATION WITH PETVIVO HOLDINGS, INC. UNVEILS REVOLUTIONARY AUTONOMOUS PET AI ECOSYSTEM TRANSFORMING PET CARE WITH SELF-LEARNING MULTI-AGENT AI TECHNOLOGYMay 13, 2025 | globenewswire.comPetVivo Holdings, Inc. Announces Participation in the D. Boral Capital Inaugural Global ConferenceMay 2, 2025 | newsfilecorp.comPETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH EQ ESPECIALIDADESApril 16, 2025 | globenewswire.comPetVivo closes Series B Convertible Preferred Stock offeringApril 2, 2025 | markets.businessinsider.comPETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF SERIES B CONVERTIBLE PREFERRED STOCK OFFERINGMarch 31, 2025 | globenewswire.comPetVivo, Digital Landia announce partnership for Agentic AI solutionsMarch 3, 2025 | markets.businessinsider.comPetvivo Holdings, Inc. and Digital Landia Corp. Announce Groundbreaking Strategic Alliance Agreement to Pioneer Agentic AI for Animal CommunicationMarch 3, 2025 | globenewswire.comPetVivo Holdings Renames Subsidiary to Focus on Animal HealthFebruary 28, 2025 | tipranks.comPetvivo Holdings, Inc. to Exhibit at the Western Veterinary Conference in Las Vegas, NevadaFebruary 19, 2025 | globenewswire.comPetVivo Holdings, Inc.: PetVivo Reports Fiscal Q3 2025 ResultsFebruary 15, 2025 | finanznachrichten.dePetVivo signs exclusive sales, marketing agreement with VetStemFebruary 14, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeGCTK, NRXS, NXGL, and PETV Company DescriptionsGlucoTrack NASDAQ:GCTK$6.32 +0.09 (+1.44%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$6.42 +0.09 (+1.50%) As of 06/20/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.NeurAxis NASDAQ:NRXS$2.54 0.00 (0.00%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$2.52 -0.02 (-0.94%) As of 06/20/2025 06:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.NexGel NASDAQ:NXGL$2.36 -0.05 (-2.07%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$2.38 +0.02 (+1.06%) As of 06/20/2025 06:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.PetVivo NASDAQ:PETV$0.80 +0.10 (+14.21%) As of 06/20/2025 03:29 PM EasternPetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes Marvell's New AI Chip Deals Capture Wall Street’s Attention Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer GE Aerospace Turns Engines Into Long-Term Profits 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
